Enanta Pharmaceuticals (NASDAQ:ENTA) reported its Q1 earnings results on Tuesday, February 8, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Enanta Pharmaceuticals missed estimated earnings by 35.78%, reporting an EPS of $-1.48 versus an estimate of $-1.09.
Revenue was up $4.09 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0, which was followed by a 15.06% increase in the share price the next day.
Here's a look at Enanta Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.22 | -1.26 | -0.97 | -0.74 |
| EPS Actual | -1.22 | -1.19 | -1.09 | -0.41 |
| Revenue Estimate | 26.34M | 22.14M | 24.85M | 28.79M |
| Revenue Actual | 23.57M | 21.62M | 20.13M | 31.74M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
